TI
TARA icon

Trexquant Investment’s Protara Therapeutics TARA Stock Holding History

Trexquant Investment’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$93.4K Buy
+17,933
New +$106K ﹤0.01% 1706
2022
Q2 		– Sell
-16,313
Closed -$83K – 1856
2022
Q1 		$83K Buy
16,313
+1,158
+8% +$6.09K ﹤0.01% 1283
2021
Q4 		$102K Buy
15,155
+2,701
+22% +$18.6K 0.01% 1233
2021
Q3 		$86K Buy
+12,454
New +$97.1K 0.01% 1063

Other funds holding TARA

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Trexquant Investment's TARA Position: Q1 2026 in Review

Trexquant Investment opened a new position in Protara Therapeutics (TARA) in Q1 2026: 17,933 shares worth $93.4K. The stake represents ﹤0.01% of the portfolio and ranks #1706 among its holdings. This is a return to the name: Trexquant Investment previously reported a position in TARA as recently as Q1 2022.

Trexquant Investment first reported a position in TARA in Q3 2021 and has held it in 4 quarters since. The position peaked at $102K in Q4 2021. 114 funds tracked by Wall St. Rank hold TARA as of Q1 2026.

  • Trexquant Investment held 17,933 shares of Protara Therapeutics worth $93.4K as of Q1 2026.
  • Protara Therapeutics was a new Trexquant Investment position in Q1 2026.
  • Protara Therapeutics made up ﹤0.01% of Trexquant Investment's portfolio in Q1 2026, its #1706 holding.
  • Trexquant Investment first reported a position in Protara Therapeutics in Q3 2021 and has held it in 4 quarters since.
  • Trexquant Investment's Protara Therapeutics position peaked at $102K in Q4 2021.
  • 114 funds tracked by Wall St. Rank held Protara Therapeutics as of Q1 2026.

Based on Trexquant Investment's 13F filing for Q1 2026, filed 15 May 2026.